Search research articles
Contact Us
Filters
Showing results (31-40 of 117) with videos related to
Page
of 12
Sort By:
Open Medicine (Warsaw, Poland)
|
September 21, 2018
Ipragliflozin Ameliorates Liver Damage in Non-alcoholic Fatty Liver Disease
Teruki Miyake, Sakiko Yoshida, Shinya Furukawa, et al.
Cancers
|
November 14, 2023
Survival Improvements in Advanced Hepatocellular Carcinoma with Sequential Therapy by Era
Yoshiko Nakamura, Masashi Hirooka, Atsushi Hiraoka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
May 7, 2025
Impact of muscle volume changes following atezolizumab-bevacizumab therapy in patients with unresectable hepatocellular carcinoma
Hironori Ochi, Joji Tani, Tetsu Tomonari, et al.
Journal of Gastroenterology and Hepatology
|
April 11, 2024
Changes in clinical outcomes in Japanese patients with hepatocellular carcinoma due to hepatitis C virus following the development of direct-acting antiviral agents
Hideko Ohama, Atsushi Hiraoka, Toshifumi Tada, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
November 1, 2022
Significance of ramucirumab following atezolizumab plus bevacizumab therapy for hepatocellular carcinoma using real-world data
Shigeo Shimose, Rie Sugimoto, Atsushi Hiraoka, et al.
BMC Cancer
|
June 15, 2021
AFP and eGFR are related to early and late recurrence of HCC following antiviral therapy
Takao Watanabe, Yoshio Tokumoto, Kouji Joko, et al.
Journal of Gastroenterology and Hepatology
|
May 27, 2025
Comparison of Surgical Resection and Radiofrequency Ablation for Early-Stage HCC Patients With Child-Pugh Class B
Takeshi Hatanaka, Satoru Kakizaki, Atsushi Hiraoka, et al.
European Journal of Gastroenterology & Hepatology
|
June 27, 2025
Identification of high-risk group for diabetes-associated hepatocellular carcinoma using noninvasive test for liver fibrosis
Kazuya Kariyama, Kazuhiro Nouso, Atsushi Hiraoka, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
February 9, 2026
Effect of Disease Extent on Leucine-Rich α2-Glycoprotein as a Marker for Endoscopic Mucosal Healing in Patients With Ulcerative Colitis
Shogo Kitahata, Mai Saito, Yuka Kimura, et al.
Oncology
|
March 30, 2025
Cachexia Index as a Prognostic Indicator in Patients with Unresectable Hepatocellular Carcinoma Receiving Atezolizumab and Bevacizumab Therapy
Khanh Van Nguyen, Kosuke Matsui, Hisashi Kosaka, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 117) with videos related to
Sort By:
Page
of 12
Open Medicine (Warsaw, Poland)
|
September 21, 2018
Ipragliflozin Ameliorates Liver Damage in Non-alcoholic Fatty Liver Disease
Teruki Miyake, Sakiko Yoshida, Shinya Furukawa, et al.
Cancers
|
November 14, 2023
Survival Improvements in Advanced Hepatocellular Carcinoma with Sequential Therapy by Era
Yoshiko Nakamura, Masashi Hirooka, Atsushi Hiraoka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
May 7, 2025
Impact of muscle volume changes following atezolizumab-bevacizumab therapy in patients with unresectable hepatocellular carcinoma
Hironori Ochi, Joji Tani, Tetsu Tomonari, et al.
Journal of Gastroenterology and Hepatology
|
April 11, 2024
Changes in clinical outcomes in Japanese patients with hepatocellular carcinoma due to hepatitis C virus following the development of direct-acting antiviral agents
Hideko Ohama, Atsushi Hiraoka, Toshifumi Tada, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
November 1, 2022
Significance of ramucirumab following atezolizumab plus bevacizumab therapy for hepatocellular carcinoma using real-world data
Shigeo Shimose, Rie Sugimoto, Atsushi Hiraoka, et al.
BMC Cancer
|
June 15, 2021
AFP and eGFR are related to early and late recurrence of HCC following antiviral therapy
Takao Watanabe, Yoshio Tokumoto, Kouji Joko, et al.
Journal of Gastroenterology and Hepatology
|
May 27, 2025
Comparison of Surgical Resection and Radiofrequency Ablation for Early-Stage HCC Patients With Child-Pugh Class B
Takeshi Hatanaka, Satoru Kakizaki, Atsushi Hiraoka, et al.
European Journal of Gastroenterology & Hepatology
|
June 27, 2025
Identification of high-risk group for diabetes-associated hepatocellular carcinoma using noninvasive test for liver fibrosis
Kazuya Kariyama, Kazuhiro Nouso, Atsushi Hiraoka, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
February 9, 2026
Effect of Disease Extent on Leucine-Rich α2-Glycoprotein as a Marker for Endoscopic Mucosal Healing in Patients With Ulcerative Colitis
Shogo Kitahata, Mai Saito, Yuka Kimura, et al.
Oncology
|
March 30, 2025
Cachexia Index as a Prognostic Indicator in Patients with Unresectable Hepatocellular Carcinoma Receiving Atezolizumab and Bevacizumab Therapy
Khanh Van Nguyen, Kosuke Matsui, Hisashi Kosaka, et al.
Page
of 12